Year: 2021

OXFORD, United Kingdom, Nov. 24, 2021 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines, today announced that Bill Enright, Chief Executive Officer, and Georgy Egorov, Chief Financial Officer, are participating at the 33rd Annual Virtual Piper Sandler Healthcare Conference November 30th to December 2nd, 2021. A pre-recorded fireside chat with Bill Enright and Georgy Egorov is available at the link below.Event: 33rd Piper Sandler Annual Healthcare ConferenceFireside Chat: Virtual on-demand webcastTime/date: 10 a.m. EST, Nov. 22 and available for approximately 90 daysWebcast: Events section of the Vaccitech websiteAbout Vaccitech plcVaccitech is a clinical-stage biopharmaceutical company engaged...

Focus on the discovery and development of novel therapeutic strategies to treat obesity and its related metabolic disorders TORONTO, Nov. 24, 2021 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (CSE: CMND, FSE: CWY0, OTC Pink: CMNDF), (“Clearmind” or the “Company”), a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and undertreated health problems, is pleased to announce it has signed an agreement to fund a new research and development project with the Hebrew University of Jerusalem’s Obesity and Metabolism Laboratory, to evaluate the Company’s proprietary compound, MEAI’s direct effect on binge eating including food and water intakes as well as activity and metabolic parameters. The study, which will be overseen by Prof. Joseph (Yossi)...

Over 9 months of 2021, Grigeo AB group (hereinafter – the Group), consisting of Grigeo AB, Grigeo Packaging UAB, Grigeo Baltwood UAB, Grigeo Klaipėda AB, Mena Pak AT, Grigeo Recycling UAB, Grigeo Recycling SIA and Grigeo investicijų valdymas UAB achieved the consolidate sales turnover of EUR 117.8 million. It is by EUR 21.0 million more than over 9 months of 2020. Over the reporting period, the Group earned EUR 11.7 million profit before taxes, which is by EUR 2.6 million more than in the same period in 2020. Earnings before interest, taxes, depreciation, and amortization (EBITDA) of the Group, if compared with 9 months of 2021, increased by EUR 1.4 million and reached EUR 19.2 million. Over 9 months of 2021, Grigeo AB (hereinafter – the Company) sales amounted to EUR 48.8 million, which is by EUR 0.9 million more than in the same period...

GLYFADA, Greece, Nov. 24, 2021 (GLOBE NEWSWIRE) — Globus Maritime Limited (“Globus” or the “Company”) (NASDAQ: GLBS), a dry bulk shipping company, announced today that it will release financial results for the three- and nine-months period ended September 30, 2021, after the market closes in New York on Tuesday, November 30, 2021. About Globus Maritime Limited Globus is an integrated dry bulk shipping company that provides marine transportation services worldwide and presently owns, operates, and manages a fleet of eight dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina and other dry bulk cargoes internationally. Globus’ subsidiaries own and operate eight vessels with a total carrying capacity of 544,420DWT and a weighted average age of 10.6 years as of November 24, 2021. Safe Harbor Statement This...

LONDON, Nov. 24, 2021 (GLOBE NEWSWIRE) — Ferroglobe PLC (NASDAQ: GSM) (“Ferroglobe” or “the Company”), a leading producer of silicon metal, silicon-based alloys and manganese-based alloys, announced today that it will postpone its virtual Investor Day to Q1-2022 due to unforeseen circumstances resulting in a scheduling conflict. Marco Levi, Ferroglobe’s Chief Executive Officer stated, “We are excited to host the first investor day since I joined Ferroglobe in 2020. We have been working diligently to turnaround this Company and look forward to this opportunity to tell our story, as we take significant steps to drive change and enhance our competitiveness to maximize our potential. We previously announced a target date for our investor day in late November; however due to an unforeseen scheduling conflict we have to postpone the...

EDGEWOOD, N.Y., Nov. 24, 2021 (GLOBE NEWSWIRE) — CPI Aerostructures, Inc. (“CPI Aero” or “Company”) (NYSE American: CVU) announced that on November 23, 2021, it received a notice from the NYSE American LLC (“Exchange”) informing the Company that the Exchange had accepted CPI Aero’s plan to regain compliance with the Exchange’s standards for continued listing of its common stock under the timely filing criteria included in the NYSE American Company Guide. The Exchange has granted CPI Aero until April 14, 2022, to regain compliance with the timely filing criteria. If the Company is unable to cure the delinquency by April 14, 2022, the Company may request an additional extension up to the maximum cure period of May 24, 2022. In addition, if the Company does not make progress consistent with the plan during the plan period or if the...